Production (Stage)
Blueberries Medical Corp.
BBM
CNSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 323.94% | 8.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 323.94% | 8.76% | |||
| Cost of Revenue | 1,331.52% | -70.42% | |||
| Gross Profit | 62.82% | 251.49% | |||
| SG&A Expenses | -6.09% | 5.87% | |||
| Depreciation & Amortization | -0.51% | 8.94% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 52.89% | -4.62% | |||
| Operating Income | 20.05% | 7.67% | |||
| Income Before Tax | -113.88% | 46.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -113.88% | 46.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -113.88% | 46.25% | |||
| EBIT | 20.05% | 7.67% | |||
| EBITDA | 22.77% | 9.44% | |||
| EPS Basic | -133.33% | 50.00% | |||
| Normalized Basic EPS | 0.00% | 50.00% | |||
| EPS Diluted | -133.33% | 50.00% | |||
| Normalized Diluted EPS | 0.00% | 50.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||